Results 81 to 90 of about 14,575 (205)
ABSTRACT Objective To explore the experiences of women and clinicians during the introduction of uterine transplantation (UTx) to the UK. Design A qualitative study utilising prospective case study methodology (interviews and observations) over 6 years.
Daisy Elliott +13 more
wiley +1 more source
A whole‐exome sequencing–based mutational signature biomarker (MSBM) identified an HRD‐enriched population in advanced ovarian cancer. In a phase II trial, olaparib maintenance suggested clinically meaningful PFS benefit without bevacizumab, supporting MSBM as a complementary HRD assessment approach.
Katsutoshi Oda +20 more
wiley +1 more source
Kiaušintakio gerybiniai intraepiteliniai pokyčiai: klinikinis atvejis ir mokslinės literatūros apžvalga [PDF]
Serous tubal intraepithelial lesion (STIL) is a rare benign lesion of the fallopian tube epithelium characterized by atypical epithelial cells with morphological anomalies, marked by the accumulation of p53 protein and normal or slightly increased ...
Tretjakova, Ksenija +1 more
core +2 more sources
MTAP Deficiency as a Metabolic Vulnerability in Cancer: Implications for Synthetic Lethal Therapy
MTAP deletion creates a therapeutically actionable metabolic vulnerability through MTA accumulation and PRMT5 dependency. This review summarizes the biochemical basis of MTAP‐directed synthetic lethality, emerging PRMT5/MAT2A inhibitors, clinicogenomic features of MTAP‐deleted tumors, and future strategies for precision oncology.
Hiroaki Ikushima, Hidenori Kage
wiley +1 more source
Metaplastic papillary tumour of the salpinx: report of a case with microsatellite analysis [PDF]
Metaplastic papillary tumour (MPT) of the salpinx is a rare lesion found in the lumen of Fallopian tubes during the post-partum period. This lesion is very small and microscopically is composed of papillae lined by stratified epithelium.
AZZONI, Cinzia +11 more
core +1 more source
Off‐label nivolumab treatment guided by CGP results was evaluated in 56 patients with advanced solid tumors. TMB‐High was the predominant biomarker leading to nivolumab treatment. Nivolumab showed limited clinical benefit in 50 patients with measurable disease, with an ORR of 16.0%, DCR of 40.0%, median PFS of 2.7 months, and median OS of 7.2 months ...
Masashi Kanai +16 more
wiley +1 more source
Introduction: Neoplasms of the female genital tract show considerable histopathological diversity, with leiomyomas being the most frequent benign tumors and carcinomas of the endometrium, cervix, and ovary representing significant malignant entities ...
Shirish S. Chandanwale +4 more
doaj +1 more source
Advancing collagen‐related pathology assessment through second‐harmonic generation imaging
Abstract Collagen remodelling and dysregulation are the hallmarks of diverse pathological conditions. In this context, second‐harmonic generation (SHG) imaging has emerged as a powerful label‐free modality for assessing collagen. This offers submicron resolution, intrinsic optical sectioning, and deeper imaging capabilities without the need for ...
Jackson Rodrigues +7 more
wiley +1 more source
Abstract 5480: Expression and function of EVI1 and EVI1s (Δ324) ovarian cancer [PDF]
Objective: The MDS1 and EVI1 complex locus (MECOM) located at the 3q26 locus is amplified in many cancers and gives rise to a number of alternatively spliced transcripts and proteins including EVI1 and MDS1-EVI1 (ME).
Susan Dalton +5 more
core +1 more source
Guidance for Specialised Cancer Nursing of People With Gynaecological Cancers: A Scoping Review
ABSTRACT Background Gynaecological cancer nurses are crucial to the delivery of quality, specialised care to meet the needs of people with these cancers. The extent of evidence‐based guidance to support nursing care is unknown. Aim To identify and describe existing international guidance for specialised gynaecological cancer nursing care.
Natalie Williams +4 more
wiley +1 more source

